Cycling without brakes lets ALL escape

In this issue of Blood, Boldrin et al(1) identify a novel biomarker of poor out-come in acute lymphoblastic leukemia (ALL), and delineate the biological link between miR-497/195 repression and more aggressive disease.

Automated summary

This study in Blood identifies a novel biomarker for poor outcome in acute lymphoblastic leukemia (ALL) and elucidates the biological connection between miR-497/195 repression and more aggressive disease.